Sir,
Succinylcholine is a blocker of neuromuscular transmission widely used for rapid sequence intubation. Despite its potential severe side-effects, its quick onset of action and short-acting make it the treatment of choice for rapid sequence intubation. [1] Major side effects reported are hyperkalemia, histamine release, increased of intracranial and intraocular pressures and malignant hyperthermia when associated to halothane. [2] In children, it is known that succinylcholine associated with halothane can be responsible for severe masseter spasm. [3] [4] [5] We report a case of severe masseter spasm related to succinylcholine in a child.
The patient was a 5-year-old girl suffering from Rett syndrome. Before this hospitalization, she did not suffer from apnea, trismus and chronic respiratory failure. She presented a severe form of convulsive encephalopathy. She was admitted in our hospital for respiratory distress. Her fi rst clinical examination revealed a moderate respiratory distress with fever up to 40.2°C. Laboratory studies revealed normal serum chemistry, a C-reactive protein at 200 mg/l (nl < 5 mg/l), procalcitonin at 4.59 ng/l (nl < 0.5 ng/l) and lactacidemia were normal. Tests for infl uenza A & B were negative. After 48 h, her respiratory condition worsened and required pediatric Intensive Care Unit admittance. After 24 h of noninvasive ventilation, she showed neurological impairment and hypercapnia on arterial blood gases (PaCO 2 76 mmHg) and needed invasive mechanical ventilation. This fi rst orotracheal intubation by a 4.5 mm cuffed endotracheal tube was done under propofol sedation without any complication. After 3 weeks, we attempted to wean the patient from mechanical ventilation. She was extubated and put on non-invasive ventilation support. After a few hours, she was severely hypercapnic and developed generalized tonic-clonic seizures and required re-intubation in an emergency. Therefore, rapid sequence intubation was done with ketamine (2 mg/kg) and succinylcholine (1 mg/kg). Cricoid pressure was maintained during all the procedure. Flaccid paralysis was obtained 20 s after administration of succinylcholine, but the mouth could not be opened and masseter muscles seemed to be in spasm. Additional 1 mg/kg of succinylcholine was administered without any signifi cant effect. After 10 min, despite mask-ventilation by a self-infl ated bag, the hypoxic cardiac arrest happened, and a small mouth opening allowed us to place a cuffed 4 mm orotracheal tube. This masseter spasm had been noticed by a physician during almost 20 h after use of succinylcholine which was quite surprising. A high dose of midazolam was successfully used to stop generalized tonic-clonic seizures. No other medication or anesthetic gases were used. No hyperthermia was noticed. Post-cardiac arrest laboratory results showed respiratory acidosis with normal lactate level, acute liver cytolysis (ASAT: 2056 UI/L and ALAT: 1109 UI/L), normal kidney function, and subnormal creatinine kinase (125 UI/L).
Twenty-four hours later, dysfunction of the cuffed orotracheal tube required a re-intubation that was performed under vecuronium. No masseter spasm was observed. Normal vaccination status against tetanus was noted in the history.
Protective hypothermia was done during 24 h. Brain magnetic resonance imaging 5 days after the prolonged cardiac arrest did not show post-ischemic damages.
The use of succinylcholine for rapid sequence intubation has shown its usefulness. It increases the safety and success rate of rapid intubation. We describe here, a rare case of a severe masseter spasm during rapid sequence intubation in a patient suffering from Rett syndrome.
Use of succinylcholine in patient suffering from myopathy is not recommended because of a high-risk of rhabdomyolysis and hyperkalemia but to our knowledge, no association between masseter spasm, succinylcholine and Rett syndrome is actually known. However, Rett syndrome is associated with severe dystonia and trismus which could be a risk factor for using succinylcholine. [6] Our case report raises some questions about the use of succinylcholine in rapid sequence intubation. Indeed, despite its effi ciency, many adverse effects must be known by the young emergency physician to anticipate them. Finally, in this case of severe masseter spasm, use of vecuronium, a non-depolarizing neuromuscular blocker, allowed us a safety re-intubation.
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System of adverse drug reactions reporting:
What, where, how, and whom to report?
Sir, The continuous progress in medical and pharmaceutical sciences has made the availability of pharmaceutical products in the Indian market to prevent and control of several disease conditions. Irrespective of the benefi ts associated with the use of medicines adverse effects associated with them has emerged the challenges of monitoring Adverse Drug Reactions (ADRs) over large population base. World Health Organization (WHO) defined ADR as "A response which is noxious and unintended, and which occurs at doses normally used in humans for the prophylaxis, diagnosis, or therapy of disease, or for the modification of physiological function." [1] To improve public health, the safe use of medicine must be monitored through an effective pharmacovigilance (PV) system. PV is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects, or any other possible drug-related problems. [2] Indian Pharmacopoeia Commission (IPC), Ghaziabad is functioning as a National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI). One Hundred and fi fty ADR monitoring centres (AMCs) were established in various medical institutions/hospitals across India to monitor and collect ADR reports under NCC-PvPI. [3] 
What to Report
PvPI encourages all types of suspected ADRs reporting whether they are known, unknown, serious, or nonserious, frequent, or rare regardless of an established causal relationship between a drug and the reaction. ADRs related with the use of allopathic medicines, vaccines, traditional medicines, medical devices, contrast media, etc., can be reported.
